CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $17,224,593
- in 1 filing
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-12 | Lizzul Paul F. Chief Medical Officer | Grant or award · Performance Stock Units | +16,667 | 16,667 | ||
| 2026-01-08 | Lizzul Paul F. Chief Medical Officer | Sale | −3,650 | $44.71 | $163K | 42,088 |
| 2026-01-07 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion | +8,525 | 45,738 | ||
| 2026-01-07 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −8,525 | 25,575 | ||
| 2026-01-07 | Lizzul Paul F. Chief Medical Officer | Sale | −2,235 | $45.11 | $101K | 37,213 |
| 2026-01-06 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion | +6,145 | 39,448 | ||
| 2026-01-06 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −6,145 | 6,145 | ||
| 2026-01-06 | Lizzul Paul F. Chief Medical Officer | Grant or award · Restricted Stock Unit | +21,400 | 21,400 | ||
| 2026-01-06 | Lizzul Paul F. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +29,000 | 29,000 | ||
| 2026-01-05 | Lizzul Paul F. Chief Medical Officer | Sale | −4,219 | $43.26 | $183K | 33,303 |
| 2026-01-03 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion | +10,555 | 37,522 | ||
| 2026-01-03 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −10,555 | 21,110 | ||
| 2025-12-22 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion 10b5-1 | +1,500 | $18.50 | $28K | 28,467 |
| 2025-12-22 | Lizzul Paul F. Chief Medical Officer | Sale 10b5-1 | −1,500 | $50.00 | $75K | 26,967 |
| 2025-12-22 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 | −1,500 | 83,500 | ||
| 2025-01-07 | Lizzul Paul F. Chief Medical Officer | Grant or award · Restricted Stock Unit | +34,100 | 34,100 | ||
| 2025-01-07 | Lizzul Paul F. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +97,200 | 97,200 | ||
| 2025-01-06 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion | +6,145 | 27,904 | ||
| 2025-01-06 | Lizzul Paul F. Chief Medical Officer | Shares withheld for taxes | −2,261 | $15.30 | $35K | 25,643 |
| 2025-01-06 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −6,145 | 12,290 |
Page 1 of 3 · 52 trades